✦ LIBER ✦

Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor

✍ Scribed by Hiro Tatetsu; Fumihiko Matsuno; Noritaka Takatsu; Hirosada Miyake; Koyu Hoshino; Kisato Nosaka; Kentaro Horikawa; Hiroyuki Hata; Hiroaki Mitsuya; Norio Asou

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 86 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of low-dose cytarabine and aclaru

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

✍ Si-Xuan Qian; Jian-Yong Li; Tian Tian; Yun-Feng Shen; Yuan-Qiang Jiang; Hua Lu; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Salvage therapy with endostatin, low-dos

Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia

✍ Baijun Fang; Yuzhang Liu; Jian Zhou; Yanan Li; Yongping Song 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

Combination chemotherapy with low-dose c

Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient

Continuous drip infusion of low dose cyt

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

✍ Nobuhiro Kanemura; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Toshiki Yamada 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (Ara‐C) and etoposide (VP‐16) (AV therapy) for those elderly AML patients